Our mission

Funding is essential when it comes to setting up innovative research. Via the AFIP platform you too can help us conduct crucial research by donating (info ANBI status read below). We work towards a comprehensive collaboration between doctors, researchers, and patients, with the aim of sharing our findings with you. Additionally, we seek to include the input from patients in the design of new research projects.

Setting up new studies with AFIP’s members

The team consists of the research groups of Prof. dr. Bianca Brundel and Prof. dr. Natasja de Groot. Our mission is to improve the treatment of the arrhythmia atrial fibrillation through innovative research into the mechanisms, diagnostics and possible drugs against this arrhythmia. We set up these investigations jointly with the members of the AFIP Foundation.

AFIP’s purpose

The aim of the AFIP Foundation is to work alongside the community as means of developing new atrial fibrillation treatments. We want to shift from general solutions to personalized solutions.

Learn about atrial fibrillation

The AFIP Foundation breaks down the most relevant topics, so that you may have informed conversations with your doctor or relatives.

Co-creation of solutions

With your collaboration, we can set up new studies to combat atrial fibrillation.

.

Donate to AFIP

Your contribution is much needed to support our community and our work.

Proud collaboration with

The sponsors of the AFIP foundation help us take a step closer to a world without atrial fibrillation. Financial contributions make it possible for us to conduct innovative studies. However, sponsors have no influence over our research. Would your organization also want to support us?

Become a partner

Founders of AFIP

Atrial Fibrillation Innovation Platform (AFIP) was founded in 2016 by Prof. dr. Bianca Brundel (VUmc, Amsterdam) and Prof. dr. Natasja
de Groot (EMC, Rotterdam). Since 2014, they have set up various joint research projects that, among other things, provide support to the Dutch Heart Foundation and the Technology and Science Foundation (Halt&Reverse, Atrial Fibrillation Finger Printing).

On this website you will find information about our mission, developments in the field of diagnosis and treatment of atrial fibrillation,
findings of our scientific studies, our research groups in VUmc and EMC, our contact information, and our investigation.

Prof. Dr. Bianca Brundel | Co-Founder at AFIP | Molecular and cellular biologist at VUMC Amsterdam

Prof. dr. dr. Bianca Brundel has been researching the molecular mechanisms responsible for the development and aggravation of atrial fibrillation for 20 years. She also strives to discover new targets for medicines. She began this research in 1996 at the UMCG in Groningen, under the supervision of Prof. I. van Gelder and Prof. dr. H. Crijns, both experts in the clinical treatment of atrial fibrillation. For her research, Prof. Brundel developed unique experimental model systems for atrial fibrillation: the cultured cardiac cell model and Drosophila (fruit flies) model. She has successfully used both systems to unravel mechanisms responsible for atrial fibrillation and has been able to identify potential medicine. She also works closely with (inter)national researchers such as Prof. dr. S. Nattel (Montreal Heart Institute, Canada) and Dr. N. de Groot (EMC). Since January 2016 she has been working at the Physiology department of the VUmc in Amsterdam.

Ms. Agnes Muskens-Heemskerk | Ms. Agnes Muskens-Heemskerk - Communication Manager at AFIP Foundation

Agnes Muskens has been a certified nurse since 1975 and subsequently specialized as an Intensive Care nurse.

Since 2000 worked as a nurse assistant in the Department of Clinical Electrophysiology. Here she wrote the first ICD patient brochure for the EMC in 2001. She also organized patient information days for this target group. She started after 2006 as a research nurse in clinical electrophysiology.

Since 2018 she has been involved with the AFIP foundation, where she is the point of contact for all questions, among other things. She also supports the studies of the AFIP foundation and is the point of contact for the participants in these studies.

Ms. Myrthe Kuipers | Ms. Myrthe Kuipers | Co-founder and Program Director AFIP Foundation

Since the establishment of AFIP in 2016, Myrthe Kuipers has been working for the foundation as a project manager. Myrthe has an MSc in Business Administration with a specialization in Digital Business (UvA).

As a project manager, Myrthe is involved in raising awareness about atrial fibrillation. She is also involved in increasing patient involvement in the AFIP foundation. For this she coordinates the brainstorming group consisting not only of patients with atrial fibrillation, but also researchers in this field. In addition, she takes care of communication between the different target groups, and organizes educational meetings for patients to provide background information about atrial fibrillation, as well as information about the latest results of research.

Dr-Natasja-de-Groot

Prof. dr. Natasja de Groot | Prof. dr. Natasja de Groot | Cardiologist - Electrophysiologist at Erasmus Medical Center

Prof. dr. Natasja MS de Groot works as a cardiologist-electrophysiologist (electrophysiologist is a medical specialist in the treatment of cardiac arrhythmias) at the Erasmus Medical Center in Rotterdam. She studied medicine at the University of Leiden after which she undertook PhD research into the mechanism of atrial arrhythmias at both the Leiden University Medical Center and the Cardiovascular Research Institute Maastricht. She completed her training as a cardiologist at the Leiden University Medical Center. Since 2009 she has been working at the Erasmus Medical Center where she leads the translational electrophysiology research group. She is also the principal investigator of the Academic Center of Excellence for Atrium Fibrillation.

She is co-author of several international guidelines on the diagnosis and treatment of cardiac arrhythmias. In her clinical activities she specializes in the treatment of atrial arrhythmias in patients with congenital heart defects, cardiac arrhythmias in children, and genetically determined cardiac arrhythmias. In 2014 she was appointed Associate Professor and in 2015 she became a board member of the European Heart Rhythm Association, where she is responsible for communication with healthcare professionals and patients within the European member states.

What does AFIP Foundation do with donations?

AFIP has a General Benefit Institution (ANBI) status. As such, the assets of the AFIP foundation are managed by the directors of the foundation. No board members receive remuneration for the duties, nevertheless they do supervise the expenses of the foundation.

The assets of the foundation are used exclusively to maintain the website or to purchase materials that are necessary for the development of new studies. If the foundation is ever dissolved, all assets will be transferred to comparable foundations such as the Dutch Heart Foundation and Hart4research.

Your contribution is neccessary
Supported by your donations…
Man in Lab

Opening

Genetic AF clinic

We heard you. A significant number of AF patients indicated AF runs in the family and now we’re opening the first clinic in Europe to investigate this finding.

Trial

L-Glutamine

Input from a patient enabled us to conduct a clinical study on the effect of L-glutamine in patients with atrial fibrillation.